Last reviewed · How we verify
NCT07049874
The Effect of Huel on Markers of Inflammation
NA trial testing Huel in 4 Weeks Supplementation of Huel Ready to Eat Foods in 30 participants. Participants enrolled and being followed up; not accepting new ones.
1 August 2025
Quick facts
| Lead sponsor | Newcastle University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 30 |
| Start date | 1 February 2025 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 August 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Huel
Conditions studied
- 4 Weeks Supplementation of Huel Ready to Eat Foods — all drugs for 4 Weeks Supplementation of Huel Ready to Eat Foods →
Sponsor
Newcastle University
Who can join
18 and older, any sex, with 4 Weeks Supplementation of Huel Ready to Eat Foods. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will assess the effect of Huel on markers of gastrointestinal inflammation of 30 generally healthy individuals. The aim is to identify any changes in the markers of inflammation status of volunteers in any of the 9 markers to be monitored. Inflammation status will be measured at the start of the study, after one week of their habitual diets and again after four weeks of consuming two ready to drink Huel products per day, one Hot \& Savoury Huel (grain-based option only) and the remainder of their calorie intake to be made up of Huel Powder (v3.1).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07049874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Newcastle University trials
Trials by the same sponsor.
- NCT07206433 — Transient Ischemic Attack (TIA) and Spoken Language · not yet recruiting
- NCT07128004 — In This Study, we Are Testing Whether Combining Two Interventions, in the Early Stages of Tinnitus, is More Effective in · NA · not yet recruiting
- NCT06551012 — Neuromuscular Fatigability in Individuals With Heart Failure · NA · not yet recruiting
- NCT05713474 — Micro-EMG: A Novel Multi-electrode System for Intramuscular Imaging · recruiting
- NCT06061419 — The Effect of Huel Powder on Appetite · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07049874 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Newcastle University
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07049874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing